SPARTHA MEDICAL is developing an anti-COVID-19 spray The start-up SPARTHA MEDICAL has received funding from the French National Research Agency (ANR) for the development of a spray capable of removing COVID-19 from a large number of surfaces. The anti-viral solution … Read More
SPARTHA MEDICAL develops a new solution against COVID-19: a nasal and oral spray The start-up is developing an anti-viral coating. Its application would initially be hospital-based, but the technology can also be developed for the general public. It comes in … Read More
SPARTHA MEDICAL HAS BEEN SELECTED FOR NETVA PROGRAMME 2020 SPARTHA Medical is one of the 14 Laureates of NETVA 2020 North America DeepTech programme organised by French Ministry of Foreign Affairs.As a part of the programme SPARTHA Medical will have … Read More
Un spray antiviral efficace contre le covid-19 ? C’est ce que développe actuellement Spartha Medical, biotech strasbourgeoise soutenue par l’ANR, Agence nationale de la recherche. Read more
En un coup de spray, défendre sa bouche et ses narines du coronavirus… Avec quelques autres pulvérisations, protéger le matériel d’une chambre d’hôpital… Il faudra attendre plusieurs mois pour savoir si les recherches de SPARTHA Medical permettront cette révolution. L’Agence … Read More
TERMINANION: SPARTHA Medical was granted a collaborative project by ANR(French National research agency). SPARTHA Medical with 2 INSERM units(INSERM 110 and 1121) will develop sprayable anti-viral coatings agains SARS-COV-2. Read more
SPARTHA Medical presentation in the official magazine of University of Strasbourg « @Savoir(s) » https://savoirs.unistra.fr/vivre-ensemble/generation-start-up/start-up-en-maceration-collective/
SPARTHA Medical has been selected for the Invest Horizon Accelerator program (https://investhorizon.eu/). The accelerator supports Deep Tech companies for their Serie A investments from 2.5 Million Euros. InvestHorizon
Pulcherie Matsodoum Nguemté joins the @SparthaMedical team as Business Developer on February 2020 After completion of a PhD in Plant Biotechnology and Environment, my enthusiasm for innovation and my concern to be an actor in technology transfer and companies scalability … Read More
In January 2020, SPARTHA Medical team was proud to become a partner in PANBioRA Project (https://www.panbiora.eu/) in order to contributing to the development of new, smart, personalised coatings for medical devices with minimized risks thanks to PANBioRA technologies.
Cynthia Calligaro joins the team on January 2020 as Production Manager. Ms. Calligaro will be responsible for the product development, evaluation and testing of SPARTHA coatings. We warmly welcome her.